Literature DB >> 24352343

Impact of liver disease severity and etiology on the occurrence of diabetes mellitus in patients with liver cirrhosis.

Jean Michel Petit1, Samia Hamza, Fabien Rollot, Vanessa Sigonney, Elodie Crevisy, Laurence Duvillard, Jean Jacques Raab, Jean Pierre Bronowicki, Brigitte Bernard-Chabert, Vincent Di Martino, Michel Doffoel, Helene Barraud, Carine Richou, Jean Louis Jouve, Patrick Hillon.   

Abstract

The association between liver cirrhosis (LC) and diabetes mellitus (DM) is well known. However, the impact of the severity or etiology of LC on the occurrence of DM is relatively unknown. We aimed to determine the prevalence and clinical correlates of DM in a large cohort of patients with cirrhosis. A total of 1,068 patients with LC were included in this cross sectional study (CIRCE study). The diagnosis of cirrhosis irrespective of its etiology was based on histological confirmation by liver biopsy or, in the absence of biopsy, on typical clinical, morphological and biological data. Data related to the cirrhosis etiology: alcohol, viral markers of hepatitis B, C, iron load parameters and autoimmune markers were collected for each patient. Venous blood samples were taken in the morning after 12-h overnight fasting. There were 383 patients with cirrhosis associated with hepatocellular carcinoma (HCC). DM was found in 412 (39.7 %) patients. Patients with DM were older and more likely to be overweight and male, with a family history of DM and a diagnosis of HCC. DM was not associated with a history of stroke or myocardial infarction. Cirrhosis secondary to hepatitis infection was less strongly associated with DM than with NASH or alcoholic cirrhosis. The severity of LC was not associated with DM. In multivariate analysis, the factors associated with DM were age, BMI, a family history of DM, and statin use. There was a significant interaction between HCC and cirrhosis etiology for the risk of DM. Cirrhosis secondary to hepatitis was associated with a lesser presence of DM only in patients with HCC (interaction p = 0.0015). LC was strongly associated with DM, with around 40 % of diabetic patients. In the group of patients with LC without HCC, diabetes was not associated with the etiology of cirrhosis.

Entities:  

Mesh:

Year:  2013        PMID: 24352343     DOI: 10.1007/s00592-013-0538-y

Source DB:  PubMed          Journal:  Acta Diabetol        ISSN: 0940-5429            Impact factor:   4.280


  6 in total

1.  Diabetes Is Associated with Clinical Decompensation Events in Patients with Cirrhosis.

Authors:  Tsai-Ling Liu; Justin Trogdon; Morris Weinberger; Bruce Fried; A Sidney Barritt
Journal:  Dig Dis Sci       Date:  2016-08-01       Impact factor: 3.199

Review 2.  Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise.

Authors:  G Liamis; T D Filippatos; A Liontos; M S Elisaf
Journal:  Hepatol Int       Date:  2016-06-21       Impact factor: 6.047

3.  Pharmacological inhibition of Receptor Protein Tyrosine Phosphatase β/ζ (PTPRZ1) modulates behavioral responses to ethanol.

Authors:  Rosalía Fernández-Calle; Marta Vicente-Rodríguez; Miryam Pastor; Esther Gramage; Bruno Di Geronimo; José María Zapico; Claire Coderch; Carmen Pérez-García; Amy W Lasek; Beatriz de Pascual-Teresa; Ana Ramos; Gonzalo Herradón
Journal:  Neuropharmacology       Date:  2018-05-09       Impact factor: 5.250

4.  Who Treats Patients with Diabetes and Compensated Cirrhosis.

Authors:  Tsai-Ling Liu; A Sidney Barritt; Morris Weinberger; John E Paul; Bruce Fried; Justin G Trogdon
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240

5.  Chronic hepatitis B virus infection status is more prevalent in patients with type 2 diabetes.

Authors:  Jun Lu; Xuhong Hou; Hong Tu; Zhenghao Tang; Yongbing Xiang; Yuqian Bao; Jianren Gu; Weiping Jia
Journal:  J Diabetes Investig       Date:  2017-03-13       Impact factor: 4.232

6.  Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus.

Authors:  Baochi Liu; Mingrong Cheng; Lin Lang; Lei Li; Yanhui Si; Guangmian Wang
Journal:  Front Physiol       Date:  2021-11-18       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.